Jurkowska G, Dlugosz J W, Rydzewska G, Andrzejewska A
Gastroenterology Department, University Medical School, Bialystok, Poland.
J Physiol Pharmacol. 1996 Dec;47(4):629-40.
Prostacyclin (PGI2) and its stable analogue iloprost (I) exert beneficial effect in acute pancreatitis (AP). The aim of the study was to evaluate the role of iloprost in pancreas regeneration after AP in rats.
AP was induced in male Wistar rats by s.c. injections of caerulein 12 micrograms/kg t.i.d. for 2 days. Rats were divided into four groups: control + saline (C); control + iloprost (C/I); AP + saline (AP); AP + I (AP/I). Rats were treated for 7 or 14 days. I (Schering AG) was given at the dose I microgram/kg b.w., i.p., t.i.d. After the rats were killed, the pancreata were weighed and their protein, DNA, RNA, chymotrypsin, alpha-amylase contents were evaluated. Light microscopic examination of representative pieces of pancreas was performed.
Acute pancreatitis resulted in pancreas destruction observed even 7 days after the onset of the disease. The significant decrease of pancreatic weight, RNA and chymotrypsin contents were observed in AP rats when compared to C. The improvement of pancreatic histology and significant increase of DNA content were found in I treated (during 7 days) AP rats in comparison to untreated AP group. Two weeks after pancreatitis induction the pancreas regeneration occurred in both pancreatitis groups and it was connected with pancreas hypertrophy. Treatment with I resulted in slight not significant increase of some of cellular hypertrophy indices when compared to AP untreated animals. Healthy rats injected with I during 7 days showed significant elevation of DNA content in comparison to C. When treatment with I was prolonged up to 14 days such hyperplastic effect was not observed. Our results suggest, that treatment with iloprost exerts temporary hyperplastic influence on the pancreas of healthy rats and pancreas regenerating after caerulein-induced pancreatitis.
前列环素(PGI2)及其稳定类似物伊洛前列素(I)在急性胰腺炎(AP)中发挥有益作用。本研究旨在评估伊洛前列素在大鼠急性胰腺炎后胰腺再生中的作用。
通过皮下注射12微克/千克雨蛙素,每日3次,共2天,诱导雄性Wistar大鼠发生急性胰腺炎。大鼠分为四组:对照组 + 生理盐水(C);对照组 + 伊洛前列素(C/I);急性胰腺炎组 + 生理盐水(AP);急性胰腺炎组 + 伊洛前列素(AP/I)。大鼠治疗7天或14天。伊洛前列素(先灵公司)以1微克/千克体重的剂量腹腔注射,每日3次。大鼠处死后,称取胰腺重量,并评估其蛋白质、DNA、RNA、胰凝乳蛋白酶、α淀粉酶含量。对胰腺代表性切片进行光镜检查。
急性胰腺炎导致胰腺破坏,甚至在疾病发作7天后仍可观察到。与对照组相比,急性胰腺炎大鼠的胰腺重量、RNA和胰凝乳蛋白酶含量显著降低。与未治疗的急性胰腺炎组相比,接受伊洛前列素治疗(7天)的急性胰腺炎大鼠的胰腺组织学得到改善,DNA含量显著增加。胰腺炎诱导两周后,两个胰腺炎组均发生胰腺再生,且与胰腺肥大有关。与未治疗的急性胰腺炎动物相比,伊洛前列素治疗导致一些细胞肥大指标略有增加,但无显著差异。与对照组相比,健康大鼠注射伊洛前列素7天显示DNA含量显著升高。当伊洛前列素治疗延长至14天时,未观察到这种增生效应。我们的结果表明,伊洛前列素治疗对健康大鼠的胰腺以及雨蛙素诱导的胰腺炎后再生的胰腺具有暂时的增生影响。